Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients von Mori, Joakin O., White, Jason, Elhussin, Isra, Duduyemi, Babatunde M., Karanam, Balasubramanyam, Yates, Clayton, Wang, Honghe

Volltext

Longer prostate stromal cell telomere length is associated with increased risk of death from other cancers von Mori, Joakin O, Platz, Elizabeth A, Lu, Jiayun, Brame, Alexandria, Han, Misop, Joshu, Corinne E, De Marzo, Angelo M, Meeker, Alan K, Heaphy, Christopher M

Volltext

Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer von Mori, Joakin O, Keegan, Joshua, Flynn, Rachel L, Heaphy, Christopher M

Volltext

Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins von Mori, Joakin O., Shafran, Jordan S., Stojanova, Marija, Katz, Mark H., Gignac, Gretchen A., Wisco, Jonathan J., Heaphy, Christopher M., Denis, Gerald V.

Volltext

Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer von Mori, Joakin O., Elhussin, Isra, Brennen, W. Nathaniel, Graham, Mindy K., Lotan, Tamara L., Yates, Clayton C., De Marzo, Angelo M., Denmeade, Samuel R., Yegnasubramanian, Srinivasan, Nelson, William G., Denis, Gerald V., Platz, Elizabeth A., Meeker, Alan K., Heaphy, Christopher M.

Volltext

Abstract PR02: Identification of mechanisms of resistance to enzalutamide treatment using in vitro castration-resistant prostate cancer models von Mori, Joakin O., Lin, Hui-Xian, White, Jason, Becks, Alahni, Williams, Raven, Yates, Clayton, Wang, Honghe

Volltext